Deciphera Pharmaceuticals LLC Financials

Deciphera Pharmaceuticals Stock Summary

Deciphera Pharmaceuticals competes with ANI Pharmaceuticals, Phibro Animal, Prestige Brand, Evotec SE, and Supernus Pharmaceuticals. Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Deciphera Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.

Deciphera Pharmaceuticals Key Financial Ratios

Deciphera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Deciphera Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Deciphera Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Deciphera Pharmaceuticals competition to find correlations between indicators driving Deciphera Pharmaceuticals's intrinsic value. More Info.Deciphera Pharmaceuticals LLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Deciphera Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Deciphera Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Deciphera Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Deciphera Pharmaceuticals LLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Deciphera Pharmaceuticals LLC based on widely used predictive technical indicators. In general, we focus on analyzing Deciphera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Deciphera Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.